Terminated PHASE4 INTERVENTIONAL 3-arm NCT00825123

Effects of Heart Rate Reduction on Central Arterial Pressure in Healthy Individuals

The Influence of Heart Rate Reduction Upon Central Arterial Pressure in Younger and Older Healthy Individuals

Sponsor: Baker Heart and Diabetes Institute

Interventions Ivabradine Metoprolol Placebo

Updated 7 times since 2017 Last updated: Aug 13, 2020 Started: Oct 31, 2008 Primary completion: Nov 8, 2011 Completion: Nov 8, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Baker Heart and Diabetes Institute

See all terminations from Baker Heart and Diabetes Institute

This PHASE4 trial investigates Central Arterial Pressure and is currently terminated or withdrawn. Baker Heart and Diabetes Institute leads this study, which shows 7 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Nov 2020 — Jan 2021 [monthly]

Terminated PHASE4
Sep 2020 — Nov 2020 [monthly]

Terminated PHASE4

Status: Withdrawn → Terminated

▶ Show 2 earlier versions

Jun 2018 — Sep 2020 [monthly]

Withdrawn PHASE4
Jan 2017 — Jun 2018 [monthly]

Withdrawn PHASE4

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baker Heart and Diabetes Institute
Bayside Health

Data source: Bayside Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Melbourne, Australia